Xiangrong Biotech Receives Approval from Taiwan's Ministry of Health and Welfare to Use Human Adipose Stromal Cell Exosomes in Cosmetics

1. Date of Event: July 2, 2026 (R.O.C. Year 115) 2. Company Name: Xiangrong Biomedical Technology Co., Ltd. 3. Relationship to Company: Parent Company 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: The company has received official notification from Taiwan's Ministry of Health and Welfare confirming that its 'Human Adipose Stromal Cell Exosomes' derived from human cells may be used as an ingredient in cosmetic products. 6. Response Measures: Issuance of this material information announcement. 7. Additional Disclosures: The company's developed raw material—human adipose stromal cell-derived exosomes—has already completed international registration under the International Nomenclature of Cosmetic Ingredients (INCI) as UC-hEVEX (Human Adipose Stromal Cell Exosomes). Today's approval from the Ministry of Health and Welfare permits the use of these exosomes in cosmetics within Taiwan, which will significantly support the company's product applications and future commercial expansion both domestically and globally.